Evaluation of immunebiomarkers in Lung Cancer 

da Rocha, Pedro Filipe Simões (Date of defense: 2022-11-25)

[eng] Treatment landscape in early-stage NSCLC is rapidly changing after approval of anti-PD-1/PD-L1 in the neoadjuvant and adjuvant settings, respectively. However, biomarkers for patient selection, to predict response ...